Godavari Drugs Ltd.

View in App
95.00 -0.51 ▼-0.5%

05 December 2023, 04:01:00 PM
Volume: 7,138

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.godavaridrugs.com
Market Cap 71.89 Cr.
Enterprise Value(EV) 105.59 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.87 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 19.60 Trailing Twelve Months Ending 2023-09
Industry PE 38.71 Trailing Twelve Months Ending 2023-09
Book Value / Share 46.59 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.05 Calculated using Price: 95.46
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.75 Cr. 7,530,500 Shares
FaceValue 10
About Godavari Drugs Ltd.
The company's principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Godavari Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Godavari Drugs Ltd. Performance

View details >>
1 Day
-0.53%
1 Week
-3.57%
1 Month
+10.40%
3 Month
-12.84%
6 Month
+5.63%
1 Year
+45.93%
2 Year
+64.79%
5 Year
+297.49%
10 Year
+1020.28%

Godavari Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 32.32 9.84 11.81 4.99 6.85 10.39 18.49 19.42 12.01
Return on Capital Employed (%) 32.30 15.77 16.89 11.01 12.14 11.80 17.58 18.35 14.53
Return on Assets (%) 14.70 3.17 3.41 1.40 1.77 2.54 4.72 5.45 3.40

Godavari Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 14 16 17 18 20 24 30 33 35
Non Curr. Liab. 5 5 6 9 9 12 16 14 14 14
Curr. Liab. 17 31 34 37 46 51 51 58 74 78
Minority Int.
Equity & Liab. 35 51 56 63 74 84 91 101 121 127
Non Curr. Assets 8 10 13 16 17 23 24 27 34 39
Curr. Assets 27 40 43 47 56 61 68 74 87 89
Misc. Exp. not W/O
Total Assets 35 51 56 63 74 84 91 101 121 127

Godavari Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 55 71 76 64 84 96 123 161 160 151
Other Income 0 0 1 1 0 0 0 0 1 1
Total Income 55 71 76 65 84 96 123 161 160 152
Total Expenditure -49 -67 -70 -60 -78 -90 -113 -150 -150 -141
PBIDT 6 5 6 5 6 6 10 12 11 11
Interest -1 -2 -3 -2 -3 -3 -3 -3 -4 -5
Depreciation -1 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation -1 -1 -1 0 -1 0 -2 -2 -1 -1
Exceptional Items 0 0
PAT 4 1 2 1 1 2 4 5 4 4
Adjusted EPS 5 2 2 1 2 3 5 7 5 5

Godavari Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 2 -6 -5 5 4 4 6 1 11 13
Cash Fr. Inv. -2 0 -2 -3 -3 -2 -7 -1 -5 -9
Cash Fr. Finan. 0 6 7 -2 0 -1 0 0 -6 -4
Net Change 0 0 0 0 1 0 0 0 1 1
Cash & Cash Eqvt 0 0 1 1 2 2 1 2 2 3

Godavari Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 56.13 56.13 56.36 56.92 56.92 53.12 53.12 53.16 53.16
Public 43.87 43.87 43.64 43.08 43.08 46.88 46.88 46.84 46.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 14.51 5.18 5.16 5.11 5.11 1.25 0.12 1.25 1.25

Godavari Drugs Ltd. Announcements

View details >>
Wed, 15 Nov 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release in connection with un-audited financial results for quarter and half year ended 30th september 2023
Wed, 15 Nov 2023
Regarding Lease Of Land In Kushnoor Industrial Area Nanded Maharastra
Board has approved the offer letter on 14.11.2023 and accepted to release payment of Rs. 48.89 Lakhs towards earnest money to Maharashtra Industrial Development Corporation (MIDC) for lease of land for long term in Plot No C-8 Kushnoor Industrial area Nanded Maharashtra the area of plot is 71 114.00 Square meters
Tue, 14 Nov 2023
Board Meeting Outcome for Godavari Drugs Limited (The ''Company'') Held On Tuesday November 14 2023
Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Tuesday November 14 2023

Godavari Drugs Ltd. Technical Scans

View details >>
Tue, 05 Dec 2023
High Increase in 1 Month High Increase in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years

Godavari Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,541.53 1,240.10 +0.7%
Divi's Laboratories Ltd. 99,355.60 3,744.50 -1.4%
Cipla Ltd. 98,827.76 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. 96,346.31 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. 80,129.03 5,569.05 -1.0%
Mankind Pharma Ltd. 78,038.63 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. 71,060.00 2,101.30 -1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.81 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 74.60 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-09 28.62 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.92 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.88 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 60.88 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.27 2,101.30 -1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 7.84 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-09 3.98 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.78 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.33 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 9.26 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.59 2,101.30 -1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,101.30 -1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.30 -1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.30 -1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,101.30 -1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,101.30 -1.4%

Godavari Drugs Ltd. FAQ's

What is Godavari Drugs share price?
Can I buy Godavari Drugs shares now?
What is the Market Cap of Godavari Drugs?
What are the key metrics to analyse Godavari Drugs?
What is the 52 Week High and Low of Godavari Drugs?
What is the trend of Godavari Drugs share price?